Thailand Immunization Review – WHO Report
- A recent external review highlights significant achievements within Thailand's Expanded Programme on Immunization (EPI).
- The review specifically commends Thailand's robust surveillance systems for vaccine-preventable diseases.
- Despite its successes, the review identifies areas requiring attention to ensure continued progress and address emerging challenges.
Thailand’s Immunization Program: A Comprehensive Review
Table of Contents
Published September 25, 2024
Strengths and Progress
A recent external review highlights significant achievements within Thailand’s Expanded Programme on Immunization (EPI). The program demonstrates strong commitment to preventing vaccine-preventable diseases and has successfully integrated new vaccines, such as those against rotavirus and pneumococcal disease, into its routine immunization schedule. This integration has demonstrably improved coverage rates for these critical vaccines.
The review specifically commends Thailand’s robust surveillance systems for vaccine-preventable diseases. These systems allow for the early detection of outbreaks and informed public health responses, contributing to the overall effectiveness of the EPI. Data quality and the use of surveillance data for program betterment were also noted as key strengths.
Areas for Enhancement
Despite its successes, the review identifies areas requiring attention to ensure continued progress and address emerging challenges. One key advice focuses on strengthening subnational immunization planning and microplanning. This involves improving the precision of identifying and reaching underserved populations, particularly those in remote areas or with limited access to healthcare.
The review also suggests enhancing the capacity of healthcare workers through ongoing training and professional development. Specifically, training should focus on updated immunization guidelines, effective communication strategies, and the management of adverse events following immunization (AEFI).Improved AEFI surveillance and reporting are crucial for maintaining public trust and ensuring vaccine safety.
Supply Chain and Logistics
Maintaining a reliable vaccine supply chain is paramount. The review points to the need for continued investment in cold chain infrastructure and logistics management to ensure vaccines remain potent and accessible throughout the country. This includes strengthening monitoring systems to track vaccine storage temperatures and prevent wastage.
Furthermore, the review emphasizes the importance of addressing vaccine hesitancy through targeted communication campaigns. These campaigns should be evidence-based, culturally sensitive, and designed to address specific concerns within different communities. Building trust and fostering open dialog are essential for maximizing immunization coverage.
Future Outlook and Strategic Direction
Looking ahead to 2025 and beyond, the review underscores the need for Thailand to proactively adapt its EPI to address evolving epidemiological landscapes and emerging vaccine technologies. This includes exploring the potential introduction of new vaccines and strengthening collaboration with regional and global health partners. Sustained political commitment and adequate financial resources will be critical for achieving these goals.
The recommendations from this review provide a roadmap for Thailand to further strengthen its immunization program and protect its population from vaccine-preventable diseases. Continued investment in these areas will contribute to improved public health outcomes and a more resilient healthcare system.